vs
HERITAGE COMMERCE CORP（HTBK）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是HERITAGE COMMERCE CORP的1.4倍（$75.5M vs $53.6M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 15.6%），HERITAGE COMMERCE CORP自由现金流更多（$61.3M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 12.8%）
本文介绍的企业主体信息与内容描述不符，描述内容实际为美国商会，该商会成立于1912年4月23日，是美国规模最大的游说类商业协会 advocacy 团体，成立之初得益于时任总统威廉·霍华德·塔夫脱与劳工商务部长查尔斯·内格尔推动，旨在代表工商界发声。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
HTBK vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.4倍
$53.6M
营收增速更快
PBYI
高出12.1%
15.6%
自由现金流更多
HTBK
多$46.9M
$14.4M
两年增速更快
PBYI
近两年复合增速
12.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $53.6M | $75.5M |
| 净利润 | $15.1M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 41.0% | 22.7% |
| 净利率 | 28.2% | — |
| 营收同比 | 15.6% | 27.7% |
| 净利润同比 | 42.3% | — |
| 每股收益（稀释后） | $0.25 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HTBKPBYI
| Q4 25 | $53.6M | $75.5M | ||
| Q3 25 | $50.0M | $54.5M | ||
| Q2 25 | $47.8M | $52.4M | ||
| Q1 25 | $46.1M | $46.0M | ||
| Q4 24 | $46.4M | $59.1M | ||
| Q3 24 | $42.2M | $80.5M | ||
| Q2 24 | $41.7M | $47.1M | ||
| Q1 24 | $42.1M | $43.8M |
净利润HTBKPBYI
| Q4 25 | $15.1M | — | ||
| Q3 25 | $14.7M | $8.8M | ||
| Q2 25 | $6.4M | $5.9M | ||
| Q1 25 | $11.6M | $3.0M | ||
| Q4 24 | $10.6M | — | ||
| Q3 24 | $10.5M | $20.3M | ||
| Q2 24 | $9.2M | $-4.5M | ||
| Q1 24 | $10.2M | $-4.8M |
毛利率HTBKPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率HTBKPBYI
| Q4 25 | 41.0% | 22.7% | ||
| Q3 25 | 41.1% | 17.6% | ||
| Q2 25 | 18.7% | 12.7% | ||
| Q1 25 | 35.4% | 8.7% | ||
| Q4 24 | 31.8% | 22.6% | ||
| Q3 24 | 34.3% | 27.4% | ||
| Q2 24 | 31.3% | -4.6% | ||
| Q1 24 | 34.2% | -5.3% |
净利率HTBKPBYI
| Q4 25 | 28.2% | — | ||
| Q3 25 | 29.4% | 16.2% | ||
| Q2 25 | 13.4% | 11.2% | ||
| Q1 25 | 25.2% | 6.5% | ||
| Q4 24 | 22.9% | — | ||
| Q3 24 | 24.9% | 25.2% | ||
| Q2 24 | 22.1% | -9.6% | ||
| Q1 24 | 24.1% | -11.0% |
每股收益（稀释后）HTBKPBYI
| Q4 25 | $0.25 | $0.26 | ||
| Q3 25 | $0.24 | $0.17 | ||
| Q2 25 | $0.10 | $0.12 | ||
| Q1 25 | $0.19 | $0.06 | ||
| Q4 24 | $0.17 | $0.40 | ||
| Q3 24 | $0.17 | $0.41 | ||
| Q2 24 | $0.15 | $-0.09 | ||
| Q1 24 | $0.17 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $708.6M | $130.3M |
| 总资产 | $5.8B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资HTBKPBYI
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M | ||
| Q1 24 | — | $107.2M |
总债务HTBKPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益HTBKPBYI
| Q4 25 | $708.6M | $130.3M | ||
| Q3 25 | $700.0M | $115.3M | ||
| Q2 25 | $694.7M | $104.7M | ||
| Q1 25 | $696.2M | $97.1M | ||
| Q4 24 | $689.7M | $92.1M | ||
| Q3 24 | $685.4M | $71.1M | ||
| Q2 24 | $679.2M | $48.5M | ||
| Q1 24 | $676.3M | $51.0M |
总资产HTBKPBYI
| Q4 25 | $5.8B | $216.3M | ||
| Q3 25 | $5.6B | $202.9M | ||
| Q2 25 | $5.5B | $194.9M | ||
| Q1 25 | $5.5B | $196.2M | ||
| Q4 24 | $5.6B | $213.3M | ||
| Q3 24 | $5.6B | $220.7M | ||
| Q2 24 | $5.3B | $205.0M | ||
| Q1 24 | $5.3B | $214.1M |
负债/权益比HTBKPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $61.7M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $61.3M | $14.4M |
| 自由现金流率自由现金流/营收 | 114.3% | 19.1% |
| 资本支出强度资本支出/营收 | 0.7% | 0.0% |
| 现金转化率经营现金流/净利润 | 4.08× | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流HTBKPBYI
| Q4 25 | $61.7M | $14.4M | ||
| Q3 25 | $18.9M | $9.7M | ||
| Q2 25 | $8.0M | $14.1M | ||
| Q1 25 | $14.8M | $3.6M | ||
| Q4 24 | $39.0M | $15.6M | ||
| Q3 24 | $5.3M | $11.0M | ||
| Q2 24 | $10.5M | $1.0M | ||
| Q1 24 | $7.3M | $11.2M |
自由现金流HTBKPBYI
| Q4 25 | $61.3M | $14.4M | ||
| Q3 25 | $18.8M | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | $37.3M | $15.6M | ||
| Q3 24 | $4.9M | $11.0M | ||
| Q2 24 | $9.9M | $1.0M | ||
| Q1 24 | $6.9M | — |
自由现金流率HTBKPBYI
| Q4 25 | 114.3% | 19.1% | ||
| Q3 25 | 37.7% | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | 80.5% | 26.4% | ||
| Q3 24 | 11.6% | 13.7% | ||
| Q2 24 | 23.6% | 2.1% | ||
| Q1 24 | 16.4% | — |
资本支出强度HTBKPBYI
| Q4 25 | 0.7% | 0.0% | ||
| Q3 25 | 0.1% | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | 3.5% | 0.0% | ||
| Q3 24 | 1.0% | 0.0% | ||
| Q2 24 | 1.6% | 0.0% | ||
| Q1 24 | 1.0% | 0.0% |
现金转化率HTBKPBYI
| Q4 25 | 4.08× | — | ||
| Q3 25 | 1.28× | 1.10× | ||
| Q2 25 | 1.25× | 2.41× | ||
| Q1 25 | 1.28× | 1.21× | ||
| Q4 24 | 3.67× | — | ||
| Q3 24 | 0.50× | 0.54× | ||
| Q2 24 | 1.14× | — | ||
| Q1 24 | 0.72× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
